{"id":"W4391115649","doi":"10.1016/j.jaad.2023.11.068","title":"Efficacy and safety of apremilast in pediatric patients with moderate-to-severe plaque psoriasis: 16-week results from SPROUT, a randomized controlled trial","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":26,"is_retracted":false,"has_abstract":true,"ca_institutions":"Stollery Children's Hospital; University of Alberta","funders":"LEO Pharma; European Academy of Dermatology and Venereology; Bristol-Myers Squibb; Eli Lilly and Company; Galderma; Incyte; Regeneron Pharmaceuticals; Les Laboratories Pierre Fabre; Celgene; Sanofi; Amgen; Pfizer","keywords":"Medicine; Apremilast; Plaque psoriasis; Randomized controlled trial; Psoriasis; Dermatology; Internal medicine; Psoriatic arthritis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004078173,0.001363907,0.003327606,0.0003669515,0.0004613984,0.0009676541,0.000810292,0.001601877,0.004203641],"category_scores_gemma":[0.00350685,0.0006264413,0.002996603,0.0005121531,0.0009062302,0.0009870849,0.000395916,0.002093414,0.0005188702],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006696596,"about_ca_system_score_gemma":0.001471167,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004883871,"about_ca_topic_score_gemma":0.001271661,"domain_scores_codex":[0.998077,0.001145458,0.0002029934,0.0002692963,0.0001921181,0.0001130949],"domain_scores_gemma":[0.9973688,0.000683279,0.00112039,0.0001926417,0.0001977856,0.0004369854],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9717751,0.003535518,0.001916778,0.001524098,0.002153319,0.00006883527,0.00007389172,0.0002208304,0.002147696,0.00005762492,0.0006747877,0.01585162],"study_design_scores_gemma":[0.9279395,0.06328371,0.005946476,0.0001199426,0.001237618,0.0001097849,0.00002476817,0.000214048,0.0004527334,0.00005841421,0.0005982149,0.0000147974],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9732422,0.01659652,0.0009713542,0.000570296,0.0002871634,0.004830715,0.001961093,0.0001488388,0.001391936],"genre_scores_gemma":[0.9768565,0.008654261,0.003056877,0.0009566837,0.0004790378,0.007027171,0.001753023,0.00004003577,0.001176432],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004203641,"threshold_uncertainty_score":0.02156776,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.009041776613370692,"score_gpt":0.2392488693209343,"score_spread":0.2302070927075636,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}